Gilteritinib (ASP2215)
Important Notice: For research use only. We do not sell to patients.
Loading distributor info...
Important Notice: For research use only. We do not sell to patients.
Loading distributor info...
Discription | Gilteritinib is a potent FLT3/AXL inhibitor, which showed potent antileukemic activity against AML with either or both FLT3-ITD and FLT3-D835 mutations. |
---|
Catalog Num | A14411 |
---|---|
Formula | C29H44N8O3 |
Molecular Weight | 552.71 |
CAS Number | 1254053-43-4 |
SMILES | CCC1=NC(=C(N=C1NC2CCOCC2)NC3=CC(=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC)C(=O)N |
Synonyms | ASP2215, ASP-2215, ASP 2215 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 90 mg/mL (162.83 mM) | |
Water | Insoluble | ||
Ethanol | 77 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.09 mL | 90.46 mL | 180.93 mL |
0.5 mM | 3.62 mL | 18.09 mL | 36.19 mL |
1 mM | 1.81 mL | 9.05 mL | 18.09 mL |
5 mM | 0.36 mL | 1.81 mL | 3.62 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2